Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Vitamin D derivatives as progesterone antagonists

Sep. 5, 1997

New antitumor agents from Kyorin and Sagami

Sep. 5, 1997

DepoTech seeks Canadian approval for DepoCyt

Sep. 4, 1997

AccuSite approved in Ireland and The Netherlands

Sep. 4, 1997

Vitronectin receptor antagonists described by Merck KGaA

Sep. 4, 1997

Cloning of telomerase catalytic subunit reported

Sep. 3, 1997

Merck & Co. describes nonsteroidal antiandrogen

Sep. 3, 1997

U.S. clearance for Femara

Sep. 2, 1997

Development update on Oncolym

Sep. 2, 1997

Small peptides developed at Prolifix induce apoptosis in cancer cells

Sep. 1, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...